Seoul, South Korea – Hanmi Science, the holding company of the Hanmi Group, is extending its commitment to social responsibility through a volunteer initiative providing healthy lunchboxes to children in need. The effort, which began on February 17, 2026, involves direct participation from Hanmi Science employees and underscores a growing trend of corporate involvement in addressing local community challenges. This employee-driven volunteer operate aims to support the well-being of children in the region, offering nutritious meals and fostering a sense of community.
The initiative focuses on delivering specially prepared lunchboxes, including low-sugar madeleines, to children benefiting from local community programs. A photograph released by Hanmi Science shows the low-sugar madeleines, highlighting the company’s attention to providing healthy options. This focus on nutritional value reflects a broader understanding of the link between diet and overall health, particularly for developing children. The company’s core business, Hanmi Pharmaceutical, is as well involved in the effort, demonstrating a collaborative approach to corporate social responsibility.
Hanmi Science’s Growth and Community Focus
Hanmi Science has experienced significant financial growth in recent years, reporting a record revenue of 1.3568 trillion Korean won in 2025, a 5.7% increase year-over-year. According to a report by Newsis, operating profit also saw a substantial rise of 40.2% to 138.6 billion won, with net profit increasing by an impressive 104.2% to 115.8 billion won. This financial success has enabled the company to expand its philanthropic activities, including initiatives like the healthy lunchbox program.
The company attributes its growth to a successful transition to a professional management system and strong performance in its own business sectors, including medical devices and consumer-to-business (B2C) products. The positive financial results in the fourth quarter of 2025, with revenue of 343.9 billion won, further demonstrate this upward trajectory. Hanmi Science officials have emphasized the importance of synergy between its various subsidiaries, including Hanmi Pharmaceutical and JVM, in driving overall group success.
The Importance of Corporate Social Responsibility in South Korea
Hanmi Science’s volunteer work is part of a larger trend in South Korea, where companies are increasingly expected to contribute to the well-being of their communities. This expectation is fueled by a growing awareness of social issues and a desire for businesses to play a more active role in addressing them. The focus on supporting children is particularly prevalent, reflecting a societal emphasis on education and future generations.
Recent discussions surrounding inheritance tax revisions in South Korea, as reported by Blind, have also highlighted the need for companies to demonstrate their commitment to social responsibility. While the debate centers on tax burdens, it underscores a broader conversation about wealth distribution and the role of corporations in supporting society. The timing of Hanmi Science’s volunteer initiative suggests a proactive approach to demonstrating its positive impact.
Expanding Beyond Pharmaceuticals
While Hanmi Science is closely associated with its pharmaceutical arm, Hanmi Pharmaceutical – a leading R&D-focused pharmaceutical company in South Korea – the company has diversified its business portfolio. Hanmi Pharmaceutical’s website details its significant investment in research and development, particularly in areas like diabetes and oncology. This diversification has allowed Hanmi Science to explore new avenues for growth and contribute to various sectors of the economy, including healthcare, cosmetics, and consumer health products.
The company’s success in China, where Hanmi Pharmaceutical is considered one of the most successful Korean companies, has also contributed to its overall financial strength. Beijing Hanmi Pharmaceutical operates across all aspects of the business, from R&D to sales, demonstrating a fully integrated approach to international expansion.
Looking Ahead
Hanmi Science plans to continue its investment in both its core business and its social responsibility initiatives. The company’s focus on fostering synergy between its subsidiaries and supporting local communities is expected to drive continued growth and positive impact. The next update on Hanmi Science’s financial performance is scheduled for release in May 2026, providing further insight into the company’s progress.
We encourage readers to share their thoughts on corporate social responsibility and the role of businesses in supporting their communities. Your feedback is valuable as we continue to cover these essential topics.
